Followers | 144 |
Posts | 27633 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
![](https://investorshub.advfn.com/uicon/33650.png?cb=1628859195)
Friday, June 24, 2005 11:09:54 AM
Friday June 24, 8:00 am ET
YOKNEAM, ISRAEL--(MARKET WIRE)--Jun 24, 2005 -- Syneron Medical Ltd. (NasdaqNM:ELOS - News) announced today that it has established a strategic relationship for marketing and sales in India and Russia following the receipt of regulatory approval to sell Syneron's proprietary elos(TM)-based products in both the Indian and Russian markets. In India, Syneron has signed an agreement with Suchita NuMed Tech Pvt. Ltd. and in Russia with JSC "World."
According to Syneron CEO, Moshe Mizrahy, "The two new agreements, in addition to the agreement in China announced one month ago, are part of a strategic decision in Syneron to enter these three emerging markets for medical aesthetic products in their early stage of development to ensure a strong market position in the future."
About Syneron
Syneron Medical Ltd. (NasdaqNM:ELOS - News) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos(TM) combined-energy technology of bi-polar radio frequency and light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world including North American Headquarters in Canada and European Headquarters in Germany, which provide sales, service and support. Additional information can be found at www.syneron.com.
Syneron, the Syneron logo, elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.
http://biz.yahoo.com/iw/050624/089440.html
Dubi
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM